Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 6 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 6 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 7 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 7 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 2 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 6 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine ...